Top Cannabis Investment News, Member Posts, Cannabis Investment Daily Indices and more!

2yrs ago Cannabis hightimes Views: 409

Cannabis industry powerhouse Canopy Growth Corporation announced that it has entered an agreement to acquire Wana Brands, the continent’s largest cannabis edibles brand by market share, in a deal worth nearly $300 million. Under the terms of the agreement, Canopy has secured options to purchase Wana and its related entities once THC products become federally legal in the United States. 

“As we establish Canopy Growth as the world’s leading cannabis company, acquiring the number-one cannabis edibles brand in North America will serve to strengthen our market position in both Canada and the United States,” Canopy Growth CEO David Klein said in a press release. 

“The right to acquire Wana secures another major, direct pathway into the U.S. THC market upon federal permissibility, and in Canada, we’ll be adding the top-ranked cannabinoid gummies to our industry-leading house of brands. We’re confident in the future growth of the edibles category and the tremendous opportunities with Wana.”

The agreement provides Canopy Growth the right to acquire 100 percent of the outstanding membership interests in Wana Brands and its related entities Mountain High Products, Wana Wellness and The Cima Group, upon the federal legality of THC in the U.S. market. 

When exercising the option, Canopy Growth will make an additional payment equal to 15 percent of the fair market value of each entity at the time it is acquired. The two companies will continue to operate independently until the options are exercised.

Deal Will Unite Two Major Players

Wana manufactures and sells cannabis gummies in Colorado and licenses its intellectual property to partners producing cannabis edibles in 11 other states including California, Arizona, Illinois, Michigan and Florida, as well as across Canada. 

Canopy Growth is a Canadian-based cannabis and cannabinoid consumer products company serving adult-use customers with an array of regulated marijuana products through its Tweed and Tokyo Smoke branded dispensaries in Canada. The company also operates the medical brand Spectrum Therapeutics, which is a market leader in both Canada and Germany. 

In the United States, Canopy Growth offers hemp-derived CBD products via the First & Free and Martha Stewart health and wellness brands, giving the company a global footprint in cannabis and cannabis-related products. Additionally, in 2019, Canopy Growth announced a deal giving it the right to acquire U.S. multistate cannabis operator Acreage Holdings. Canopy Growth also has a conditional ownership interest in TerraAscend, another U.S.-based MSO.

Adding Wana Brands to its portfolio gives Canopy Growth several strategic benefits, including strengthening its access to the U.S. market. The deal leverages Wana’s leadership position and continuing expansion in the U.S., where it has the largest multi-market presence of any independent cannabis edibles brand. 

When Canopy exercises the acquisition option, it will own and operate Wana’s vertically integrated production facility in Colorado as well as its licensing division, which currently has deals in 11 states with plans to cover more than 20 states by the end of 2022. 

The acquisition will also give Canopy Growth a strong position in cannabis gummies, which are one of the fastest growing segments of the Canadian and US edibles markets, accounting for 71 of all edibles purchased, according to data from Headset.

“Edibles play a key role in attracting new consumers and adding the number-one edibles brand in North America strengthens our competitive position on both sides of the border,” Klein told Forbes in an interview. “In addition to our existing relationships with Acreage and TerrAscend, the agreement with Wana furthers Canopy’s positioning for rapid entry post-permissibility to the US THC market.”

Nancy Whiteman, the co-founder and CEO of Wana Brands, said that the announcement of the deal with Canopy Growth “reflects the culmination of more than a decade of hard work, dedication and vision put forth by our employees and partners, as well as an unwavering commitment to the plant and -our customers.” 

“We have long considered what the next phase of our growth might look like, and this deal is not only a great testament to our focus on bottom line growth and fiscal diligence, but also to the value we believe Wana can bring to Canopy and its shareholders now and in the future,” Whiteman said. 

“We have met many partners along the way over the past 11 years, but none have felt like the best and right fit until today. We are incredibly humbled and honored to be part of what Canopy Growth is building in terms of the future of this industry.”

Canopy Growth to Acquire Wana Brands in $300M Deal on High Times.


Today's Cannabis Investment Headlines:

Log In for More
Access Over 250K+ Industry Headlines, Posts and Updates
Not a member yet?

Join AlphaMaven

The Premier Alternative Investment
Research and Due Diligence Platform for Investors

Free Membership for Qualified Investors and Industry Participants
  • Easily Customize Content to Match Your Investment Preferences
  • Breaking News 24/7/365
  • Daily Newsletter & Indices
  • Alternative Investment Listings & LeaderBoards
  • Industry Research, Due Diligence, Videos, Webinars, Events, Press Releases, Market Commentary, Newsletters, Fact Sheets, Presentations, Investment Mandates, Video PitchBooks & More!
  • Company Directory
  • Contact Directory
  • Member Posts & Publications
  • Alpha University Video Series to Expand Investor Knowledge
  • AUM Accelerator Program (designed for investment managers)
  • Over 450K+ Industry Headlines, Posts and Updates
ALL ALPHAMAVEN CONTENT IS FOR INFORMATIONAL PURPOSES ONLY. CONTENT POSTED BY MEMBERS DOES NOT NECESSARILY REFLECT THE OPINION OR BELIEFS OF ALPHAMAVEN AND HAS NOT ALWAYS BEEN INDEPENDENTLY VERIFIED BY ALPHAMAVEN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS. THIS IS NOT A SOLICITATION FOR INVESTMENT. THE MATERIAL PROVIDED HEREIN IS FOR INFORMATIONAL PURPOSES ONLY. IT DOES NOT CONSTITUTE AN OFFER TO SELL OR A SOLICITATION OF AN OFFER TO BUY ANY INTERESTS OF ANY FUND OR ANY OTHER SECURITIES. ANY SUCH OFFERINGS CAN BE MADE ONLY IN ACCORDANCE WITH THE TERMS AND CONDITIONS SET FORTH IN THE INVESTMENT'S PRIVATE PLACEMENT MEMORANDUM. PRIOR TO INVESTING, INVESTORS ARE STRONGLY URGED TO REVIEW CAREFULLY THE PRIVATE PLACEMENT MEMORANDUM (INCLUDING THE RISK FACTORS DESCRIBED THEREIN), THE LIMITED PARTNERSHIP AGREEMENT AND THE SUBSCRIPTION DOCUMENTS, TO ASK SUCH QUESTIONS OF THE INVESTMENT MANAGER AS THEY DEEM APPROPRIATE, AND TO DISCUSS ANY PROSPECTIVE INVESTMENT IN THE FUND WITH THEIR LEGAL AND TAX ADVISERS IN ORDER TO MAKE AN INDEPENDENT DETERMINATION OF THE SUITABILITY AND CONSEQUENCES OF AN INVESTMENT.